日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Extranodal diffuse large B-cell lymphoma: Clinical and molecular insights with survival outcomes from the multicenter EXPECT study

结外弥漫性大B细胞淋巴瘤：多中心EXPECT研究的临床和分子见解及生存结果

期刊:Cancer Communications
影响因子:24.9
doi:10.1002/cac2.70033
Chen, Si-Yuan; Xu, Peng-Peng; Feng, Ru; Cui, Guo-Hui; Wang, Li; Cheng, Shu; Mu, Rong-Ji; Zhang, Hui-Lai; Wei, Xiao-Lei; Song, Yong-Ping; Ding, Kai-Yang; Dong, Li-Hua; Zhu, Zun-Min; Yang, Shen-Miao; Wang, Xin; Liu, Ting-Bo; Hu, Jian-Da; Zheng, Xiao-Yun; Bai, Ou; Xu, Jing-Yan; Huang, Liang; Sang, Wei; Shi, Ke-Qian; Zhou, Fan; Li, Fei; Liang, Ai-Bin; Zhou, Hui; Hao, Si-Guo; Huang, Hong-Hui; Xu, Bin; Qian, Wen-Bin; Li, Cai-Xia; Li, Zhi-Ming; Wu, Chong-Yang; Wang, Xiao-Bo; Shi, Wen-Yu; Wang, Shu-Ye; Tian, Yu-Yang; Zhang, Xi; Zhou, Ke-Shu; Cui, Li-Juan; Liu, Hui; Tan, Huo; Leng, Qing; Zhao, Dong-Lu; Niu, Ting; Zhao, Wei-Li
B细胞
细胞生物学
淋巴瘤
免疫/内分泌
发表日期：2025
文献求助 收藏

Chidamide, a Histone Deacetylase Inhibitor, Combined With R-GemOx in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (TRUST): A Multicenter, Single-Arm, Phase 2 Trial

组蛋白去乙酰化酶抑制剂西达米德联合R-吉西他滨治疗复发/难治性弥漫性大B细胞淋巴瘤（TRUST）：一项多中心、单臂、II期试验

期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.70919
Zou, Qihua; Zhang, Yuchen; Zhou, Hui; Lai, Yulin; Cao, Yi; Li, Zhiming; Su, Ning; Li, Wenyu; Huang, Huiqiang; Liu, Panpan; Ye, Xu; Wu, Yudan; Tan, Huo; Zheng, Runhui; Wu, Bingyi; Yang, Hui; Zhong, Liye; Lu, Yuhong; Liang, Yang; Sun, Peng; Li, Lirong; Liu, Yingxian; Dai, Danling; Xia, Yi; Cai, Qingqing
B细胞
表观遗传
淋巴瘤
乙酰化
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

Superiority of allo-SCT to auto-SCT in high-risk T-cell lymphoblastic lymphoma/leukemia patients with aaIPI ≥3: insights from a retrospective, multicenter analysis

异基因造血干细胞移植（allo-SCT）在aaIPI≥3的高危T细胞淋巴母细胞淋巴瘤/白血病患者中优于自体造血干细胞移植（auto-SCT）：一项回顾性多中心分析的启示

期刊:Blood Science
影响因子:2.7
doi:10.1097/BS9.0000000000000222
Luo, Xiaodan; Fan, Zhiping; Zheng, Runhui; Huang, Fen; Xu, Na; Qin, Pengfei; Lin, Jingren; Wang, Chunyan; Huang, Huiqiang; Tan, Huo; Liu, Qifa
发育与干细胞
T细胞
淋巴瘤
白血病
T细胞
干细胞
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

Case report: A novel third-generation anti-CD19/CD22 CAR T-cells combined with auto-HSCT for relapsed Burkitt lymphoma

病例报告：新型第三代抗CD19/CD22 CAR T细胞联合自体造血干细胞移植治疗复发性伯基特淋巴瘤

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2024.1497736
Luo, Xiaodan; Chen, Ao; Qin, Le; Weinkove, Robert; Zhao, Rong; Ye, Ting; Chen, Sihui; Tang, Jianli; Liu, Jianbo; Huang, Jiayu; Shi, Boyun; Yuan, Danyun; Tan, Huo; Qin, Dajiang; Tang, Zhaoyang; Li, Peng; Zheng, Runhui
发育与干细胞
T细胞
淋巴瘤
CD22
T细胞
干细胞
细胞生物学
CD2
CD19
免疫/内分泌
发表日期：2024
文献求助 收藏

Higher frequency of peripheral blood CD103(+)CD8(+) T cells with lower levels of PD-1 and TIGIT expression related to favorable outcomes in leukemia patients

外周血中CD103(+)CD8(+) T细胞频率较高且PD-1和TIGIT表达水平较低与白血病患者的良好预后相关。

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2024.1437726
Liu, Lian; Lai, Wenpu; Zhuo, Xiaoling; Chen, Sihui; Luo, Xiaodan; Tan, Huo
T细胞
CD103
CD8
CD10
白血病
T细胞
TIGIT
细胞生物学
PD-1
免疫/内分泌
发表日期：2024
文献求助 收藏

Targeting TIM-3 for hematological malignancy: latest updates from the 2022 ASH annual meeting

靶向TIM-3治疗血液系统恶性肿瘤：2022年ASH年会最新进展

期刊:Experimental Hematology & Oncology
影响因子:13.5
doi:10.1186/s40164-023-00421-2
Tan, Jiaxiong; Tan, Huo; Li, Yangqiu
肿瘤
肿瘤免疫
TIM
发表日期：2023
文献求助 收藏

Epidemiological investigation of hemophagocytic lymphohistiocytosis in China

中国噬血细胞性淋巴组织细胞增生症的流行病学调查

期刊:Orphanet Journal of Rare Diseases
影响因子:3.5
doi:10.1186/s13023-021-01976-1
Yao, Shuyan; Wang, Yini; Sun, Yuan; Liu, Li; Zhang, Rui; Fang, Jianpei; Jin, Runming; Yu, Jie; Li, Fei; Bai, Jie; Zeng, Yun; Zhang, Cheng; Tan, Huo; Zhou, Fan; Chen, Yan; Zhang, Qiaohua; Wang, Zhao
细胞生物学
发表日期：2021
文献求助 收藏

A Multi-Center, Real-World Study of Chidamide for Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas in China

中国一项多中心、真实世界研究评估了西达米德治疗复发或难治性外周T细胞淋巴瘤患者的疗效

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2021.750323
Liu, Weiping; Zhao, Donglu; Liu, Ting; Niu, Ting; Song, Yongping; Xu, Wei; Jin, Jie; Cai, Qingqing; Huang, Huiqiang; Li, Zhiming; Hou, Ming; Zhang, Huilai; Zhou, Jianfeng; Hu, Jianda; Shen, Jianzhen; Shi, Yuankai; Yang, Yu; Zhang, Liling; Zhao, Weili; Ding, Kaiyang; Qiu, Lugui; Tan, Huo; Zhang, Zhihui; Liu, Lihong; Wang, Jinghua; Xu, Bing; Zhou, Hui; Gao, Guangxun; Xue, Hongwei; Bai, Ou; Feng, Ru; Huang, Xiaobing; Yang, Haiyan; Yan, Xiaojing; Zeng, Qingshu; Liu, Peng; Li, Wenyu; Mao, Min; Su, Hang; Wang, Xin; Xu, Jingyan; Zhou, Daobin; Zhang, Hongyu; Ma, Jun; Shen, Zhixiang; Zhu, Jun
T细胞
淋巴瘤
T细胞
细胞生物学
免疫/内分泌
发表日期：2021
文献求助 收藏

Eukaryotic initiation factor-2, gamma subunit, suppresses proliferation and regulates the cell cycle via the MAPK/ERK signaling pathway in acute myeloid leukemia

真核起始因子-2γ亚基通过MAPK/ERK信号通路抑制急性髓系白血病中的增殖并调节细胞周期。

期刊:Journal of Cancer Research and Clinical Oncology
影响因子:2.8
doi:10.1007/s00432-021-03712-5
Lu, Jielun; Chen, Shuyi; Tan, Huo; Huang, Zhenqian; Li, Bo; Liu, Ling; Chen, Yimin; Zeng, Xiaozhen; Zou, Yawei; Xu, Lihua
白血病
信号转导
细胞生物学
MAPK/ERK
发表日期：2021
文献求助 收藏

MicroRNA-363-3p promote the development of acute myeloid leukemia with RUNX1 mutation by targeting SPRYD4 and FNDC3B

MicroRNA-363-3p 通过靶向 SPRYD4 和 FNDC3B 促进 RUNX1 突变型急性髓系白血病的发生发展

期刊:Medicine
影响因子:1.4
doi:10.1097/MD.0000000000025807
Chen, Yimin; Chen, Shuyi; Lu, Jielun; Yuan, Danyun; He, Lang; Qin, Pengfei; Tan, Huo; Xu, Lihua
白血病
RUNX1
发表日期：2021
文献求助 收藏